Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (111-120 of 4,670) with videos related to

Pageof 467
Sort By:
Cancer Discovery|May 23, 2015
Elotuzumab May Slow Multiple Myeloma
Cancer Discovery|May 16, 2015
The NLRP3-CASP1 Inflammasome Induces Glucocorticoid Resistance in ALL
Cancer Discovery|May 16, 2015
Biofilms Enhance Metabolic Changes Associated with Colon Cancer
Cancer Discovery|May 14, 2015
T-Cell-Based Immune Therapy Treats EBV-LPD
Cancer Discovery|May 15, 2015
Targeting Mesothelin with Modified T Cells
Cancer Discovery|May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitorsGarrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Cancer Discovery|May 7, 2020
Cytokine Storm Drugs Move from CAR T to COVID-19
Cancer Discovery|May 3, 2020
Liquid Biopsies Make Strides on Cancer Detection
Cancer Discovery|May 1, 2020
<i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication StressTheresa E León, Tanya Rapoz-D'Silva, Cosetta Bertoli, et al.
Pageof 467

Showing results (111-120 of 4,670) with videos related to

Sort By:
Pageof 467
Cancer Discovery|May 23, 2015
Elotuzumab May Slow Multiple Myeloma
Cancer Discovery|May 16, 2015
The NLRP3-CASP1 Inflammasome Induces Glucocorticoid Resistance in ALL
Cancer Discovery|May 16, 2015
Biofilms Enhance Metabolic Changes Associated with Colon Cancer
Cancer Discovery|May 14, 2015
T-Cell-Based Immune Therapy Treats EBV-LPD
Cancer Discovery|May 15, 2015
Targeting Mesothelin with Modified T Cells
Cancer Discovery|May 15, 2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitorsGarrett M Frampton, Siraj M Ali, Mark Rosenzweig, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Cancer Discovery|May 7, 2020
Cytokine Storm Drugs Move from CAR T to COVID-19
Cancer Discovery|May 3, 2020
Liquid Biopsies Make Strides on Cancer Detection
Cancer Discovery|May 1, 2020
<i>EZH2</i>-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication StressTheresa E León, Tanya Rapoz-D'Silva, Cosetta Bertoli, et al.
Pageof 467